<DOC>
	<DOCNO>NCT00002160</DOCNO>
	<brief_summary>To determine safety efficacy SNX-111 controlling severe , chronic pain cancer AIDS patient .</brief_summary>
	<brief_title>A Multicenter Phase II/III , Placebo-Controlled Study SNX-111 Administered Intrathecally Cancer AIDS Patients With Chronic Pain</brief_title>
	<detailed_description>Patients randomize receive SNX-111 placebo ( AS PER AMENDMENT 1/22/98 : randomization weight 2:1 favor SNX-111 ) via external pump intrathecal catheter ( thin tube insert spinal canal ) . ( AS PER AMENDMENT 1/22/98 : dose increase every 24 hour , absence onset analgesia adverse event . After 2-5 day , patient respond medication continue treatment home 5-8 day . Patients respond switch regimen ( i.e. , placebo SNX-111 , SNX-111 placebo ) . After 10 day , respond patient unblinded ask enroll long-term , open-label extension protocol . Patients remain fixed dose therapeutic level find previous study . The dose may increase decreased discretion investigator . Patients may continue therapy long-term basis drug approve .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Ziconotide</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Rescue analgesia . Patients must : Chronic pain related AIDS cancer . Unsatisfactory response prior opioid therapy . Life expectancy &gt; 3 month ( 1 month infusion pump place ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Signs sepsis inadequately treated infection . Patients follow prior condition exclude : History heart disease , heart failure , asthma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1998</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Pain</keyword>
	<keyword>Palliative Care</keyword>
	<keyword>omega-conopeptide MVIIA</keyword>
	<keyword>Calcium Channel Blockers</keyword>
</DOC>